April 2011
Volume 52, Issue 14
Free
ARVO Annual Meeting Abstract  |   April 2011
Progression of Retinal Ganglion Cell Dysfunction is Hindered with IOP-lowering Treatment in Early Normal Tension Glaucoma
Author Affiliations & Notes
  • Olga A. Shif
    Ophthalmology, Bascom Palmer Eye Institute, Miami, Florida
  • Vittorio Porciatti
    Ophthalmology, Bascom Palmer Eye Institute, Miami, Florida
  • William J. Feuer
    Ophthalmology, Bascom Palmer Eye Institute, Miami, Florida
  • Lori M. Ventura
    Ophthalmology, Bascom Palmer Eye Institute, Miami, Florida
  • Footnotes
    Commercial Relationships  Olga A. Shif, None; Vittorio Porciatti, None; William J. Feuer, None; Lori M. Ventura, None
  • Footnotes
    Support  NIH-NEI RO1 EY014957, NIH center grant P30-EY014801, unrestricted grant to Bascom Palmer Eye Institute from Research to Prevent Blindness.
Investigative Ophthalmology & Visual Science April 2011, Vol.52, 4172. doi:
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      Olga A. Shif, Vittorio Porciatti, William J. Feuer, Lori M. Ventura; Progression of Retinal Ganglion Cell Dysfunction is Hindered with IOP-lowering Treatment in Early Normal Tension Glaucoma. Invest. Ophthalmol. Vis. Sci. 2011;52(14):4172.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract

Purpose: : To investigate progressive changes of retinal ganglion cell (RGC) function in early normal tension glaucoma (NTG) before and after IOP lowering treatment.

Methods: : Fifteen NTG glaucoma suspects with mean age 54.9 ±11.8 years (28 eyes) and corrected visual acuity ≥20/20, were followed longitudinally over 6.44 ± 1.07 years, receiving 14.2 ± 2.9 measurements of IOP, Pattern Electroretinogram (PERG) and SAP. After an untreated period, patients received topical treatment for glaucoma based on standard clinical considerations. Rates of PERG/SAP change with time (slopes) for both the untreated and treated conditions were calculated for each eye using bi-linear regression analyses with the time of 1st treated visit as a known break point. IOP measurements were averaged over untreated and treated periods.

Results: : Medians of untreated and treated measurements were significantly (P<0.001) different for IOP (15.5 mm Hg vs. 14.1 mm Hg) and PERG amplitude slope (-8.4 % /year vs. 0.14% /year), but not for SAP-MD slope (-0.08 dB/year vs. -0.02 dB/year, P = 0.85). In 27 out of 28 eyes, PERG amplitude slopes became less negative after treatment. Eight eyes out of 28 tested (28%) had significant slope improvement after treatment (P<0.001, n=6; P<0.05, n=2). Correlation analysis showed that the steeper the progressive decline of PERG signal before treatment, the larger the magnitude of recovery after treatment (Pearson’s R = -0.83, P<0.001).

Conclusions: : The results indicate that the PERG may detect progressive RGC dysfunction in early untreated NTG, as well as its potential reversibility after IOP lowering.

Keywords: ganglion cells • intraocular pressure • electroretinography: clinical 
×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×